Edwards Lifesciences Corp (EW)
Gross profit margin
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Gross profit | US$ in thousands | 4,322,000 | 4,625,000 | 4,302,000 | 3,983,600 | 3,305,700 |
| Revenue | US$ in thousands | 5,439,500 | 6,004,800 | 5,382,400 | 5,232,500 | 4,386,300 |
| Gross profit margin | 79.46% | 77.02% | 79.93% | 76.13% | 75.36% |
December 31, 2024 calculation
Gross profit margin = Gross profit ÷ Revenue
= $4,322,000K ÷ $5,439,500K
= 79.46%
Based on the provided data, the gross profit margin of Edwards Lifesciences Corp has shown a generally increasing trend over the past five years. In December 2020, the gross profit margin was 75.36%, which improved to 76.13% by December 2021. Subsequently, there was a significant increase to 79.93% by December 2022. However, in December 2023, the gross profit margin decreased slightly to 77.02% before rebounding to 79.46% by December 2024.
Overall, the company has demonstrated strong control over its cost of goods sold relative to its revenue, resulting in a consistent improvement in gross profit margins over the years. This indicates operational efficiency and effectiveness in managing production costs, which bodes well for the company's profitability and financial performance.
Peer comparison
Dec 31, 2024